Combined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxic

Keyphrases

• Cardiotoxicity 100%
• Paclitaxel 100%
• Doxorubicin 100%
• Advanced Breast Cancer 100%
• Neutropenia 50%
• Toxic Effects 25%
• Nausea-vomiting 25%
• Congestive Heart Failure 25%
• Left Ventricular Ejection Fraction 25%
• Dose Level 25%
• Treatment Course 25%
• Median Survival 25%
• Metastatic Breast Cancer 25%
• Anthracyclines 25%
• Neuropathy 25%
• Efficacy-toxicity 25%
• Duration of Response 25%
• Myalgia 25%
• Cumulative Dose 25%
• Highly Active 25%
• Overall Response Rate 25%
• Resistant Breast Cancer 25%
• Alopecia 25%
• Complete Responders 25%
• Adjuvant Chemotherapy Regimens 25%
• Optimal Scheduling 25%

Medicine and Dentistry

• Breast Cancer 100%
• Doxorubicin 100%
• Paclitaxel 100%
• Neutropenia 50%
• Cardiotoxicity 50%
• Heart Left Ventricle Ejection Fraction 25%
• Myalgia 25%
• Congestive Heart Failure 25%
• Nausea 25%
• Anthracycline 25%
• Adjuvant Chemotherapy 25%
• Neuropathy 25%
• Metastatic Breast Cancer 25%
• Alopecia Mucinosa 25%
• Chemotherapy 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Paclitaxel 100%
• Doxorubicin 100%
• Cardiotoxicity 50%
• Neutropenia 50%
• Nausea 25%
• Congestive Heart Failure 25%
• Anthracycline 25%
• Metastatic Breast Cancer 25%
• Chemotherapy Regimens 25%
• Neuropathy 25%
• Adjuvant 25%
• Myalgia 25%
• Alopecia 25%